Digestive Disease Week 2011: Highlights of clinical and preclinical research on Barrett's esophagus and associated esophageal adenocarcinoma
Departments of Gastroenterology and Hepatology Internal Medicine Surgery, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.Diseases of the Esophagus (Impact Factor: 1.78). 03/2012; 26(2). DOI: 10.1111/j.1442-2050.2012.01340.x
Clinicians and basic researchers worldwide convened at the annual Digestive Disease Week where the latest research in the field of gastroenterology and hepatology is presented. In this report, the highlights of the convention on the field of Barrett's esophagus (BE) and associated esophageal adenocarcinoma (EAC) are summarized. New clinical and preclinical developments in etiology, diagnosis, surveillance, and prevention and therapy of BE and EAC in respect to current knowledge are reflected. We also discuss the relevance and impact of these findings on the future of BE and EAC research.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.